U.S. markets close in 1 hour 12 minutes
  • S&P 500

    4,584.85
    +71.81 (+1.59%)
     
  • Dow 30

    34,700.50
    +678.46 (+1.99%)
     
  • Nasdaq

    15,376.54
    +122.49 (+0.80%)
     
  • Russell 2000

    2,208.47
    +61.04 (+2.84%)
     
  • Crude Oil

    67.02
    +1.45 (+2.21%)
     
  • Gold

    1,766.40
    -17.90 (-1.00%)
     
  • Silver

    22.40
    +0.06 (+0.27%)
     
  • EUR/USD

    1.1301
    -0.0022 (-0.19%)
     
  • 10-Yr Bond

    1.4560
    +0.0220 (+1.53%)
     
  • GBP/USD

    1.3301
    +0.0024 (+0.18%)
     
  • USD/JPY

    113.1900
    +0.4100 (+0.36%)
     
  • BTC-USD

    56,726.59
    -800.93 (-1.39%)
     
  • CMC Crypto 200

    1,440.35
    +1.47 (+0.10%)
     
  • FTSE 100

    7,129.21
    -39.47 (-0.55%)
     
  • Nikkei 225

    27,753.37
    -182.25 (-0.65%)
     

StageZero to Issue Q2 2021 Financial Results and Hold Conference Call on Tuesday, August 17

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

TORONTO, ON / ACCESSWIRE / August 11, 2021 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its second quarter 2021 operational results before the market open on Tuesday, August 17, 2021. StageZero's Chairman and CEO, James Howard-Tripp, will host a conference call and accompanying webcast at 8:30 a.m. EST on Tuesday, August 17, 2021, to review the operational results and discuss business developments.

Analyst and Investor Call

Event Date: Tuesday, August 17, 2021
Time: 8:30 a.m. EST
Webcast Link: https://www.webcaster4.com/Webcast/Page/2082/42373
Participant Numbers: Toll Free: +1 844-602-0380

International: +1-862-298-0970
Replay Number: Toll Free: +1-877-481-4010

International: +1-919-882-2331
Replay Passcode: 42373

About StageZero Life Sciences Ltd.
StageZero Life Sciences is dedicated to the early detection of multiple diseases through whole blood tests. The Company's next-generation test, Aristotle®, is the first-ever multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. StageZero's full service, telehealth platform includes access to physicians and phlebotomists who can prescribe and draw samples for individuals and groups, and the Company operates a CAP accredited and CLIA certified high-complexity reference laboratory in Richmond, Virginia. In addition, leveraging its specialty in polymerase chain reaction (PCR) testing for the early identification of cancer through blood, StageZero also provides both COVID PCR testing (swab and saliva) and blood test analysis (Antibody testing). For more information, please visit www.stagezerolifesciences.com.

STAGEZERO LIFE SCIENCES LTD.
James Howard-Tripp
Chairman & CEO

For further information please contact:
Rebecca Greco

Investor Relations
Tel: 1-855-420-7140 ext. 1838
rgreco@stagezerols.com

SOURCE: StageZero Life Sciences Ltd



View source version on accesswire.com:
https://www.accesswire.com/659399/StageZero-to-Issue-Q2-2021-Financial-Results-and-Hold-Conference-Call-on-Tuesday-August-17